Related Experiment Video
Updated: May 30, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
[Current developments in the diagnostics and therapy of bladder carcinoma]
J Kamradt1, C-H Ohlmann, M Stöckle
1Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes, Kirrbergerstrasse 1, Gebäude 6, Homburg/Saar, Germany.
Der Urologe. Ausg. A
|August 25, 2011
Summary
Early bladder carcinoma detection via urine markers remains challenging. Photodynamic diagnostics show promise for improving recurrence-free survival, pending Phase III trial confirmation.
Area of Science:
- Urology
- Oncology
- Medical Diagnostics
Context:
- Bladder carcinoma treatment has advanced, but early detection remains difficult.
- Current urine marker tests are not recommended for screening.
- Photodynamic diagnostics and resection show initial promise.
Purpose:
- To review recent advancements in bladder carcinoma management.
- To assess the efficacy of new diagnostic and therapeutic strategies.
- To highlight the evolving role of molecular markers.
Summary:
- Early bladder carcinoma detection using urine markers is challenging; no current tests are suitable for screening.
- Photodynamic diagnostics and resection improve recurrence-free survival, requiring Phase III trial validation.
- Early cystectomy may offer better prognosis for pT1G3 tumors than organ-preserving methods.
- Adjuvant chemotherapy shows increasing value, with Phase III trials confirming survival benefits.
- Molecular markers are crucial for identifying patients who could benefit from systemic chemotherapy.
Impact:
- Photodynamic diagnostics may become a standard of care for bladder carcinoma after Phase III trials.
- Adjuvant chemotherapy is increasingly recognized for its survival benefits in bladder carcinoma.
- Molecular markers will personalize bladder carcinoma treatment strategies.
Related Concept Videos
01:27Imaging Studies III: Computed Tomography
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:22Imaging Studies VI: Voiding Cystourethrography and Cystography
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...